Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
Bungard
T J
TJ
Ghali
W A
WA
McAlister
F A
FA
Buchan
A M
AM
Cave
A J
AJ
Hamilton
P G
PG
Mitchell
L B
LB
Shuaib
A
A
Teo
K K
KK
Tsuyuki
R T
RT
D000416:Alberta; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010820:Physicians / Q000523:psychology*; D012306:Risk; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin